close

Register today to unlock Valuecruncher and get unlimited access

  • Get unlimited access to all compartors and data
  • Save and share valuations as well as comment on others
  • Alter and save your favourite comparator companies

Already registered? Please login now

Comparison Analysis (switch to Discounted Cash Flow Analysis)
Dollar20Point32
Implied share price

Sell Overvalued by 79.5%

5% margin of safety What's this?

EV / EBITDA
Use Average
FRX
Forest Laboratories, Inc.
AMGN
Amgen, Inc.
Change
GILD
Gilead Sciences, Inc.
Change
DNA
Genentech, Inc.
Change
SNY
Sanofi SA (ADR)
Change
9.92 43.24 12.21 4.95 17.08 5.09
All amounts in millions
from last financial year
         
Implied Share Price $20.32 $141.23 $169.44 $56.52 $80.16
Market Cap 26,986 130,102 107,921 100,042 98,744
Net Debt 846 47 7,450 -3,369 7,330
Enterprise Value (EV) 27,833 130,149 115,371 96,673 56,725
Revenue 3,646 21,662 32,639 13,418 34,861
EBITDA 643 10,657 23,287 5,661 11,136
Percent 17.7 % 49.2 % 71.3 % 42.2 % 31.9 %
EBIT 333 8,530 22,189 5,069 7,186
Percent 9.1 % 39.4 % 68.0 % 37.8 % 20.6 %
Balance Sheet          
Total Assets 12,017 71,449 51,716 21,787 102,321
Total Liabilities 5,851 43,366 33,182 6,116 44,272
Shareholders Equity 6,165 28,083 18,534 15,671 58,049.0

Price history

Comments

No comments yet. Login to comment.